Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 16.95
-0.10 (-0.59%)
At close: Aug 28, 2026
Daiken Biomedical Revenue
Daiken Biomedical had revenue of 616.34M TWD in the quarter ending June 30, 2026, with 35.50% growth. This brings the company's revenue in the last twelve months to 2.19B, up 34.28% year-over-year. In the year 2025, Daiken Biomedical had annual revenue of 1.90B with 39.10% growth.
Revenue (ttm)
2.19B
Revenue Growth
+34.28%
P/S Ratio
6.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.65B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.90B | 532.70M | 39.10% |
| Dec 31, 2024 | 1.36B | 171.97M | 14.45% |
| Dec 31, 2023 | 1.19B | 305.45M | 34.52% |
| Dec 31, 2022 | 884.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.